Physical Therapists in Greenwich, NY Accepting Medicare
7 Physical Therapists found. Showing 1 - 7
 Carolyn Beth Chlopecki, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6 Queens Gate Dr, Greenwich, NY 12834 Phone: 518-692-1186 |
Mrs. Babette Anne Furman, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10 Gray Ave, Greenwich Central School, Greenwich, NY 12834 Phone: 518-692-9542 |
Mrs. Barbara E Hamel, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4 Main St, Greenwich, NY 12834 Phone: 518-692-3311 Fax: 518-692-8153 |
Ms. Christine Mary Burke, PT PHYSICAL THERAPIS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4 Main St, Greenwich, NY 12834 Phone: 518-692-3311 Fax: 518-692-8153 |
Mrs. Kristina Gunter, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4 Main St, Greenwich, NY 12834 Phone: 518-692-3311 Fax: 518-692-8153 |
 Helping Hands Physical Therapy, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 4 Main St, Greenwich, NY 12834 Phone: 518-692-3311 Fax: 518-692-8153 |
Darlene A O'dell, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1134 State Route 29, Greenwich, NY 12834 Phone: 518-692-9861 Fax: 518-692-7947 |
News Archive
Second pivotal efficacy study not required for MAP Pharmaceuticals' LEVADEX NDA
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
NIH awards La Jolla Institute $12.6M to develop San Diego's first Center for RNAi screening
The La Jolla Institute for Allergy & Immunology will develop San Diego's first Center for RNAi screening - a breakthrough genomics technology that will further enhance San Diego's reputation as a national research leader and provide the local biomedical community ready access to the Nobel-Prize winning technology.
Meth vs. opioids: America has two drug epidemics, but focuses on one
Kim had been wine tasting with a friend in Sonoma, Calif. They got into an argument in the car that night and Kim thought someone was following them. She was utterly convinced. And she had to get away.
AIDS United releases new infographic
According to a recent estimate by the Centers for Disease Control, nearly half of all new HIV/AIDS diagnoses in the United States are in the states of Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, and Tennessee-the same region that is leading the nation in persons living with, and dying from, AIDS.
› Verified 6 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Podiatrists
Occupational Therapists